We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVSA
701
Covista Inc
CVSA
$3.94B
$379K 0.01%
+8,000
New +$409K
PDCO
702
DELISTED
Patterson Companies, Inc.
PDCO
$374K 0.01%
19,000
– –
GIB icon
703
CGI
GIB
$13.9B
$373K 0.01%
6,102
-332
-5% -$20.5K
UHAL icon
704
U-Haul Holding Co
UHAL
$14B
$372K 0.01%
+11,330
New +$383K
QCLS
705
Q/C Technologies Inc
QCLS
$25.4M
$367K 0.01%
2
+1
+100% +$304K
CHDN icon
706
Churchill Downs
CHDN
$6.03B
$366K 0.01%
9,000
– –
INGR icon
707
Ingredion
INGR
$6.38B
$366K 0.01%
4,000
-4,000
-50% -$400K
MNDT
708
DELISTED
Mandiant, Inc. Common Stock
MNDT
$365K 0.01%
22,500
– –
XRX icon
709
Xerox
XRX
$337M
$360K 0.01%
18,213
– –
PZZA icon
710
Papa John's
PZZA
$999M
$358K 0.01%
9,000
– –
TCOM icon
711
Trip.com Group
TCOM
$27.5B
$358K 0.01%
13,245
– –
UAA icon
712
Under Armour
UAA
$3B
$341K 0.01%
19,277
-4,916
-20% -$101K
MDRX
713
DELISTED
Veradigm Inc. Common Stock
MDRX
$337K 0.01%
35,000
– –
CGNX icon
714
Cognex
CGNX
$10.3B
$333K 0.01%
8,611
-2,072
-19% -$89.8K
FBIN icon
715
Fortune Brands Innovations
FBIN
$6.12B
$331K 0.01%
+10,195
New +$385K
FTSV
716
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$314K ﹤0.01%
+20,000
New +$305K
PAGP icon
717
Plains GP Holdings
PAGP
$5.23B
$313K ﹤0.01%
15,595
-767
-5% -$17K
AOS icon
718
A.O. Smith
AOS
$8.38B
$303K ﹤0.01%
+7,086
New +$326K
PNQI icon
719
Invesco NASDAQ Internet ETF
PNQI
$501M
$302K ﹤0.01%
13,750
– –
EXAS
720
DELISTED
Exact Sciences
EXAS
$301K ﹤0.01%
+4,765
New +$327K
XBI icon
721
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$301K ﹤0.01%
4,195
+490
+13% +$39.5K
WKC icon
722
World Kinect Corp
WKC
$1.96B
$300K ﹤0.01%
+14,000
New +$369K
BUD icon
723
AB InBev
BUD
$158B
$296K ﹤0.01%
+4,500
New +$344K
SHOP icon
724
Shopify
SHOP
$148B
$287K ﹤0.01%
20,740
+4,050
+24% +$57K
KT icon
725
KT
KT
$8.84B
$284K ﹤0.01%
+19,965
New +$289K
27 28
29
30 31

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.